Fisher & Paykel Healthcare Corporation Limited Price Chart
Fisher & Paykel Healthcare Corporation Limited FPH.XA Financial and Trading Overview
Contents
- Fisher & Paykel Healthcare Corporation Limited Price Chart
- Fisher & Paykel Healthcare Corporation Limited FPH.XA Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Fisher & Paykel Healthcare Corporation Limited
- Q&A For Fisher & Paykel Healthcare Corporation Limited Stock
| Fisher & Paykel Healthcare Corporation Limited stock price | 26.46 AUD |
| Previous Close | 21.59 AUD |
| Open | 21.58 AUD |
| Bid | 21.91 AUD x N/A |
| Ask | 0 AUD x N/A |
| Day's Range | 21.58 - 22.27 AUD |
| 52 Week Range | 16.11 - 26.11 AUD |
| Volume | 83.36K AUD |
| Avg. Volume | 80.69K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.326436 |
| PE Ratio (TTM) | 37.211697 |
| EPS (TTM) | 0.59 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
FPH.XA Valuation Measures
| Enterprise Value | 12.52B AUD |
| Trailing P/E | 37.211697 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 7.253023 |
| Enterprise Value/Revenue | 7.917 |
| Enterprise Value/EBITDA | 30.569 |
Trading Information
Fisher & Paykel Healthcare Corporation Limited Stock Price History
| Beta (5Y Monthly) | 0.326436 |
| 52-Week Change | 23.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.11 AUD |
| 52 Week Low | 16.11 AUD |
| 50-Day Moving Average | 24.2 AUD |
| 200-Day Moving Average | 21.44 AUD |
FPH.XA Share Statistics
| Avg. Volume (3 month) | 80.69K AUD |
| Avg. Daily Volume (10-Days) | 67.34K AUD |
| Shares Outstanding | N/A |
| Float | 577.08M |
| Short Ratio | N/A |
| % Held by Insiders | 7.58% |
| % Held by Institutions | 36.20% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.405 |
| Trailing Annual Dividend Yield | 1.87% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 15.83% |
| Operating Margin (ttm) | 21.01% |
| Gross Margin | 59.35% |
| EBITDA Margin | 25.90% |
Management Effectiveness
| Return on Assets (ttm) | 9.63% |
| Return on Equity (ttm) | 14.58% |
Income Statement
| Revenue (ttm) | 1.58B AUD |
| Revenue Per Share (ttm) | 2.74 AUD |
| Quarterly Revenue Growth (yoy) | 13.90% |
| Gross Profit (ttm) | 938.4M AUD |
| EBITDA | 409.5M AUD |
| Net Income Avi to Common (ttm) | 250.3M AUD |
| Diluted EPS (ttm) | 0.59 |
| Quarterly Earnings Growth (yoy) | -0.50% |
Balance Sheet
| Total Cash (mrq) | 121.5M AUD |
| Total Cash Per Share (mrq) | 0.21 AUD |
| Total Debt (mrq) | 145.8M AUD |
| Total Debt/Equity (mrq) | 8.32 AUD |
| Current Ratio (mrq) | 2.671 |
| Book Value Per Share (mrq) | 3.027 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 238.2M AUD |
| Levered Free Cash Flow (ttm) | 26.94M AUD |
Profile of Fisher & Paykel Healthcare Corporation Limited
| Country | Australia |
| State | N/A |
| City | Auckland |
| Address | 15 Maurice Paykel Place |
| ZIP | 2013 |
| Phone | 64 9 574 0100 |
| Website | https://www.fphcare.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 6391 |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Q&A For Fisher & Paykel Healthcare Corporation Limited Stock
What is a current FPH.XA stock price?
Fisher & Paykel Healthcare Corporation Limited FPH.XA stock price today per share is 26.46 AUD.
How to purchase Fisher & Paykel Healthcare Corporation Limited stock?
You can buy FPH.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fisher & Paykel Healthcare Corporation Limited?
The stock symbol or ticker of Fisher & Paykel Healthcare Corporation Limited is FPH.XA.
How many shares does Fisher & Paykel Healthcare Corporation Limited have in circulation?
The max supply of Fisher & Paykel Healthcare Corporation Limited shares is 0.
What is Fisher & Paykel Healthcare Corporation Limited Price to Earnings Ratio (PE Ratio)?
Fisher & Paykel Healthcare Corporation Limited PE Ratio is 44.84220500 now.
What was Fisher & Paykel Healthcare Corporation Limited earnings per share over the trailing 12 months (TTM)?
Fisher & Paykel Healthcare Corporation Limited EPS is 0.59 AUD over the trailing 12 months.